PT-141
Desire, not just performance
PT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system rather than on blood flow, making it an option when desire is the primary concern.
- Acts centrally, not vascularly
- As-needed subcutaneous dosing
- Supplies included
- Provider oversight
PT-141 questions
Care that starts in minutes, not months.
- 01
Complete your online assessment
Answer a short, confidential medical questionnaire from home.
- 02
A licensed clinician reviews within 24–48h
A licensed U.S. clinician reviews your history. Payment does not guarantee a prescription. Your provider decides.
- 03
If approved, your medication ships discreetly
Treatment ships discreetly to your door when approved.
Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate. You will be notified through email, text/SMS, or your online Hypergevity portal if approved. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. If receiving treatment for other conditions, your provider may prescribe FDA-approved generic or brand prescription drugs. If you are unsure, always ask your provider which medication they are prescribing.
Start your visit today.
Complete a short online intake and a licensed provider will review your plan.